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Objective/purpose
Induction of IDO in dendritic cells (DCs) depletes the
essential amino acid, tryptophan, and generates a family
of catabolites known as kynurenines (KYN). IDO activity
is reported to have immunomodulatory effects, includ-
ing the selective induction of apoptosis in T-helper 1
(Th1) lymphocytes, an effect not seen with Th2 cells
that are dominant in allergic asthma. Infants hospita-
lized for RSV-related bronchiolitis have increased risk of
developing asthma (48% vs. 8% in control). Induction of
IDO activity by RSV may explain the link between RSV
bronchiolitis and asthma pathogenesis. IDO is induced
by various cytokines and a number of non-airway
viruses; however, RSV has not yet been studied. We
hypothesize that RSV induce IDO activation in human
dendritic cells (DCs).
Methods
Primary human dendritic cells (DCs) were infected with
sucrose gradient purified RSV with a multiplicity of
infection (MOI) rate of 1.0. Flow cytometry and confo-
cal microscopy were used to confirm infection. We mea-
sured KYN in culture media by a spectrophotometric
method using Ehrlich reagent. We blocked RSV infec-
tion with the RSV-mAb, Palivizumab, and UV-inactiva-
tion to determine a role for infection. The potent
competitive inhibitor of viral RNA polymerase, Riba-
virin, was used to block RSV replication and protein
synthesis. To evaluate dependency of RSV-induced IDO
induction on different cell signaling pathways, we used a
variety of specific inhibitors including MEK inhibitor I
(120 nM), MEK inhibitor II (4 μM), SB202190 (p38-
MAPK, 3 μM), JNK inhibitor II (1 μM), IKK inhibitor II
(Wedelolactone, 30 μM), IKK inhibitor III (BMS-
345541, 3 μM) and relevant negative controls.
Findings
DCs incubated with RSV showed a 35% shift in flow
cytometry compared to uninfected control DCs (n = 12)
thus confirming infection of DCs. KYN, as a marker of
IDO induction, was increased 13.2 fold in supernatants
of infected DCs compared with control DCs (43.6 vs.
3.3 μM, n = 6). Inactivation of virus by Palivizumab or
UV resulted in 99% decrease in levels of KYN compared
to controls (n = 3). Infecting DCs with higher MOI of
UV-inactivated RSV (up to 20, n = 3) did not induce
IDO. Addition of Ribavirin to culture media reduced
KYN release in a dose-dependent manner with 50%
reduction at 220 μM (n = 3), without having any block-
ing effect on positive controls (IFN-g induced KYN
release) at similar concentrations. Except for SB202190,
none of the specific inhibitors of signaling pathway
including NF-B, JNK-MAPK and MEK/ERK-MAPK
showed any significant inhibitory effect on IDO induc-
tion by RSV (n = 3). SB202190, the specific inhibitor of
P38-MAPK, blocked 51% (IC50= 300 nM) and 92% (3
μM) of KYN release (n = 3); negative controls showed
no inhibitory effect.
Deliverables
Our data showing IDO to be induced in DCs following
infection with RSV is novel. Further, the observation
that induction was dependent on viral replication was
unexpected. Although NF-B is reported to have a role
in IDO induction, our data suggest that RSV-induced
kynurenine release may occur through an NF-B-inde-
pendent pathway.
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These data support our hypothesis that RSV plays a role
in the development of an immune response towards a
Th2 pattern. Prevention of RSV infection could decrease
the incidence of asthma. We expect to be publishing
these novel findings in 2010.
Published: 26 November 2010
doi:10.1186/1710-1492-6-S3-P8
Cite this article as: Ajamian et al.: Respiratory syncytial virus replication
induces Indoleamine 2,3-dioxygenase (IDO) activation in human
dendritic cells. Allergy, Asthma & Clinical Immunology 2010 6(Suppl 3):P8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ajamian et al. Allergy, Asthma & Clinical Immunology 2010, 6(Suppl 3):P8
http://www.aacijournal.com/content/6/S3/P8
Page 2 of 2